Total Payments
$1,368
2024 Payments
$591.57
Companies
18
Transactions
63
Medicare Patients
7,494
Medicare Billing
$1.2M
Payment Breakdown by Category
Food & Beverage$1,315 (96.2%)
Education$52.22 (3.8%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,315 | 60 | 96.2% |
| Education | $52.22 | 3 | 3.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $260.53 | 13 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $249.91 | 11 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $148.46 | 6 | $0 (2024) |
| Vifor Pharma, Inc. | $111.08 | 5 | $0 (2024) |
| Aurinia Pharma U.S., Inc. | $90.55 | 4 | $0 (2023) |
| Novartis Pharmaceuticals Corporation | $86.88 | 3 | $0 (2024) |
| Amgen Inc. | $67.46 | 4 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $66.75 | 3 | $0 (2018) |
| Travere Therapeutics, Inc. | $55.75 | 2 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $47.26 | 2 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $591.57 | 26 | AstraZeneca Pharmaceuticals LP ($138.98) |
| 2023 | $466.89 | 22 | Bayer Healthcare Pharmaceuticals Inc. ($103.31) |
| 2022 | $144.63 | 7 | Bayer HealthCare Pharmaceuticals Inc. ($62.53) |
| 2021 | $41.51 | 2 | Aurinia Pharma U.S., Inc. ($22.00) |
| 2020 | $21.99 | 1 | Relypsa, Inc. ($21.99) |
| 2019 | $21.20 | 1 | AKEBIA THERAPEUTICS INC ($21.20) |
| 2018 | $40.59 | 2 | Janssen Pharmaceuticals, Inc ($40.59) |
| 2017 | $39.30 | 2 | Janssen Pharmaceuticals, Inc ($26.16) |
All Payment Transactions
63 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/19/2024 | Travere Therapeutics, Inc. | — | Food and Beverage | In-kind items and services | $23.17 | General |
| 11/12/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $24.48 | General |
| Category: DIABETES | ||||||
| 11/06/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $34.32 | General |
| Category: Cardio-renal | ||||||
| 10/30/2024 | Vifor Pharma, Inc. | Veltassa (Drug) | Food and Beverage | In-kind items and services | $20.55 | General |
| Category: Hyperkalemia | ||||||
| 10/16/2024 | Novartis Pharmaceuticals Corporation | Fabhalta (Drug) | Food and Beverage | In-kind items and services | $29.72 | General |
| Category: Immunology | ||||||
| 10/02/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $22.05 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/18/2024 | Otsuka America Pharmaceutical, Inc. | JYNARQUE (Drug) | Food and Beverage | In-kind items and services | $23.22 | General |
| Category: NEPHROLOGY | ||||||
| 09/16/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $27.93 | General |
| Category: GASTROENTEROLOGY | ||||||
| 09/11/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $28.32 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 08/27/2024 | Amgen Inc. | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $15.58 | General |
| Category: Inflammation/Rare Disease | ||||||
| 08/07/2024 | Vifor Pharma, Inc. | Veltassa (Drug) | Food and Beverage | In-kind items and services | $26.51 | General |
| Category: Hyperkalemia | ||||||
| 08/06/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $19.23 | General |
| 07/31/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $16.14 | General |
| Category: Cardio-renal | ||||||
| 07/03/2024 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $19.06 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 06/05/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $33.61 | General |
| Category: Cardio-renal | ||||||
| 05/22/2024 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $20.20 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 05/03/2024 | Otsuka America Pharmaceutical, Inc. | JYNARQUE (Drug) | Food and Beverage | In-kind items and services | $25.23 | General |
| Category: NEPHROLOGY | ||||||
| 04/24/2024 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $12.36 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 04/23/2024 | Novartis Pharmaceuticals Corporation | — | Food and Beverage | In-kind items and services | $22.99 | General |
| 03/26/2024 | Vifor Pharma, Inc. | Veltassa (Drug) | Food and Beverage | In-kind items and services | $24.70 | General |
| Category: Hyperkalemia | ||||||
| 03/13/2024 | Amgen Inc. | TAVNEOS (Drug) | Food and Beverage | In-kind items and services | $15.72 | General |
| Category: Inflammation | ||||||
| 03/13/2024 | Amgen Inc. | TAVNEOS (Drug) | Food and Beverage | In-kind items and services | $15.12 | General |
| Category: Inflammation | ||||||
| 03/05/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $22.22 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 02/23/2024 | Otsuka America Pharmaceutical, Inc. | JYNARQUE (Drug) | Food and Beverage | In-kind items and services | $21.79 | General |
| Category: NEPHROLOGY | ||||||
| 01/12/2024 | Travere Therapeutics, Inc. | — | Food and Beverage | In-kind items and services | $32.58 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 24 | 2,063 | 3,974 | $628,523 | $293,720 |
| 2022 | 19 | 1,730 | 3,360 | $594,681 | $277,740 |
| 2021 | 20 | 1,782 | 3,489 | $642,843 | $308,756 |
| 2020 | 21 | 1,919 | 3,523 | $659,964 | $275,751 |
Total Patients
7,494
Total Services
14,346
Medicare Billing
$1.2M
Procedure Codes
84
All Medicare Procedures & Services
84 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 90960 | Dialysis services, 4 or more physician visits per month (20 years or older) | Office | 2023 | 46 | 354 | $208,194 | $105,543 | 50.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 438 | 931 | $198,303 | $94,197 | 47.5% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 145 | 464 | $66,083 | $31,174 | 47.2% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 79 | 96 | $38,225 | $14,042 | 36.7% |
| 90961 | Dialysis services, 2-3 physician visits per month (20 years or older) | Office | 2023 | 33 | 55 | $26,600 | $13,286 | 49.9% |
| 90935 | Hemodialysis procedure with physician evaluation | Facility | 2023 | 52 | 192 | $29,514 | $11,404 | 38.6% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 102 | 102 | $21,930 | $8,265 | 37.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 32 | 55 | $7,920 | $3,737 | 47.2% |
| 82043 | Urine microalbumin (protein) level | Office | 2023 | 300 | 441 | $7,135 | $2,468 | 34.6% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 113 | 228 | $3,420 | $1,881 | 55.0% |
| 81002 | Urinalysis, manual test | Office | 2023 | 295 | 423 | $5,076 | $1,419 | 27.9% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 79 | 127 | $3,393 | $1,304 | 38.4% |
| 83970 | Parathormone (parathyroid hormone) level | Office | 2023 | 17 | 28 | $2,240 | $1,133 | 50.6% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 75 | 117 | $2,640 | $875.15 | 33.2% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2023 | 37 | 62 | $2,321 | $813.44 | 35.0% |
| 80048 | Blood test, basic group of blood chemicals (calcium, total) | Office | 2023 | 55 | 85 | $1,518 | $704.76 | 46.4% |
| 84550 | Uric acid level, blood | Office | 2023 | 45 | 71 | $896.02 | $314.53 | 35.1% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2023 | 16 | 17 | $797.98 | $279.82 | 35.1% |
| 90970 | Dialysis services, per day, less than full month service (20 years or older) | Office | 2023 | 16 | 30 | $483.60 | $225.40 | 46.6% |
| 82728 | Ferritin (blood protein) level | Office | 2023 | 13 | 14 | $532.84 | $187.04 | 35.1% |
| 82570 | Creatinine level to test for kidney function or muscle injury | Office | 2023 | 23 | 27 | $390.42 | $137.16 | 35.1% |
| 83550 | Iron binding capacity | Office | 2023 | 15 | 16 | $390.72 | $137.12 | 35.1% |
| 83540 | Iron level | Office | 2023 | 15 | 16 | $289.60 | $101.44 | 35.0% |
| 85651 | Red blood cell sedimentation rate, to detect inflammation, non-automated | Office | 2023 | 22 | 23 | $228.16 | $91.96 | 40.3% |
| 90960 | Dialysis services, 4 or more physician visits per month (20 years or older) | Office | 2022 | 46 | 329 | $193,491 | $99,954 | 51.7% |
About Dr. Rachel Colvin, DO
Dr. Rachel Colvin, DO is a Internal Medicine healthcare provider based in Goshen, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/06/2005. The National Provider Identifier (NPI) number assigned to this provider is 1174511992.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Rachel Colvin, DO has received a total of $1,368 in payments from pharmaceutical and medical device companies, with $591.57 received in 2024. These payments were reported across 63 transactions from 18 companies. The most common payment nature is "Food and Beverage" ($1,315).
As a Medicare-enrolled provider, Colvin has provided services to 7,494 Medicare beneficiaries, totaling 14,346 services with total Medicare billing of $1.2M. Data is available for 4 years (2020–2023), covering 84 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Other Specialties Nephrology
- Location Goshen, NY
- Active Since 10/06/2005
- Last Updated 09/27/2012
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1174511992
Products in Payments
- Kerendia (Drug) $249.91
- JYNARQUE (Drug) $148.46
- LOKELMA (Drug) $136.11
- Veltassa (Drug) $133.07
- FARXIGA (Drug) $124.42
- LUPKYNIS (Drug) $90.55
- XARELTO (Drug) $66.75
- TAVNEOS (Drug) $51.88
- JARDIANCE (Drug) $47.26
- RAYALDEE (Drug) $32.53
- Fabhalta (Drug) $29.72
- IBSRELA (Drug) $27.93
- AURYXIA (Drug) $21.20
- JESDUVROQ (Drug) $16.74
- BENLYSTA (Biological) $16.20
- KRYSTEXXA (Biological) $15.58
- TARPEYO (Drug) $14.09
- Auryxia (Drug) $13.14
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Goshen
Dr. Dicky Bhagat, M.d, M.D
Internal Medicine — Payments: $13,258
Internal Medicine $13,258
Lidia Koulova, Md, MD
Internal Medicine — Payments: $4,083
Internal Medicine $4,083
Abrar Sayeed, Md, MD
Internal Medicine — Payments: $3,768
Internal Medicine $3,768
Petr Bezdicek, Md, MD
Internal Medicine — Payments: $2,493
Internal Medicine $2,493
Mary Lim Lee, Md, MD
Internal Medicine — Payments: $2,203
Internal Medicine $2,203
Ms. Priyanka Mathias, Md, MD
Internal Medicine — Payments: $1,244
Internal Medicine $1,244